β Cells that Resist Immunological Attack Develop during Progression of Autoimmune Diabetes in NOD Mice

Cell Metabolism

Volumn 25, Issue 3, 2017, Pages 727-738

  Rui, Jinxiu ^a   Deng, Songyan ^a   Arazi, Arnon ^b   Perdigoto, Ana Luisa ^a   Liu, Zongzhi ^a   Herold, Kevan C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

autoimmunity; immune regulation; stem cell; cell

Indexed keywords

CYCLOPHOSPHAMIDE; CD3 ANTIGEN; MONOCLONAL ANTIBODY; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL DEATH; CELL GROWTH; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM SURVIVAL; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; LYMPHOCYTE; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CELL SURVIVAL; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOTHERAPY; INSULIN-SECRETING CELLS; LYMPHOCYTES; MICE, INBRED NOD; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 85012885799     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2017.01.005     Document Type: Article

References (39)

1. Akirav, E., Kushner, J.A., Herold, K.C., Beta-cell mass and type 1 diabetes: going, going, gone?. Diabetes 57 (2008), 2883–2888.
2. Akirav, E.M., Baquero, M.T., Opare-Addo, L.W., Akirav, M., Galvan, E., Kushner, J.A., Rimm, D.L., Herold, K.C., Glucose and inflammation control islet vascular density and beta-cell function in NOD mice: control of islet vasculature and vascular endothelial growth factor by glucose. Diabetes 60 (2011), 876–883.
3. Atkinson, M.A., Bluestone, J.A., Eisenbarth, G.S., Hebrok, M., Herold, K.C., Accili, D., Pietropaolo, M., Arvan, P.R., Von Herrath, M., Markel, D.S., Rhodes, C.J., How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited. Diabetes 60 (2011), 1370–1379.
4. Bader, E., Migliorini, A., Gegg, M., Moruzzi, N., Gerdes, J., Roscioni, S.S., Bakhti, M., Brandl, E., Irmler, M., Beckers, J., et al. Identification of proliferative and mature β-cells in the islets of Langerhans. Nature 535 (2016), 430–434.
5. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57 (1995), 289–300.
6. Blodgett, D.M., Nowosielska, A., Afik, S., Pechhold, S., Cura, A.J., Kennedy, N.J., Kim, S., Kucukural, A., Davis, R.J., Kent, S.C., et al. Novel observations from next-generation RNA sequencing of highly purified human adult and fetal islet cell subsets. Diabetes 64 (2015), 3172–3181.
7. Bosco, M.D., Mohanasundaram, D.M., Drogemuller, C.J., Lang, C.J., Zalewski, P.D., Coates, P.T., Zinc and zinc transporter regulation in pancreatic islets and the potential role of zinc in islet transplantation. Rev. Diabet. Stud. 7 (2010), 263–274.
8. Brode, S., Raine, T., Zaccone, P., Cooke, A., Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J. Immunol. 177 (2006), 6603–6612.
9. Chatenoud, L., Primo, J., Bach, J.F., CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J. Immunol. 158 (1997), 2947–2954.
10. Dhawan, S., Tschen, S.I., Zeng, C., Guo, T., Hebrok, M., Matveyenko, A., Bhushan, A., DNA methylation directs functional maturation of pancreatic β cells. J. Clin. Invest. 125 (2015), 2851–2860.
11. Dorrell, C., Schug, J., Canaday, P.S., Russ, H.A., Tarlow, B.D., Grompe, M.T., Horton, T., Hebrok, M., Streeter, P.R., Kaestner, K.H., Grompe, M., Human islets contain four distinct subtypes of β cells. Nat. Commun., 7, 2016, 11756.
12. Eizirik, D.L., Cnop, M., ER stress in pancreatic beta cells: the thin red line between adaptation and failure. Sci. Signal., 3, 2010, pe7.
13. Eizirik, D.L., Colli, M.L., Ortis, F., The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. 5 (2009), 219–226.
14. Ferrannini, E., Mari, A., Nofrate, V., Sosenko, J.M., Skyler, J.S., DPT-1 Study Group. Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset. Diabetes 59 (2010), 679–685.
15. Herold, K.C., Usmani-Brown, S., Ghazi, T., Lebastchi, J., Beam, C.A., Bellin, M.D., Ledizet, M., Sosenko, J.M., Krischer, J.P., Palmer, J.P., Type 1 Diabetes TrialNet Study Group. β cell death and dysfunction during type 1 diabetes development in at-risk individuals. J. Clin. Invest. 125 (2015), 1163–1173.
16. Jayaraman, S., Assessment of beta cell viability. Curr. Protoc. Cytom., Chapter 6, 2011 Unit 6.27.
17. Jonas, J.C., Sharma, A., Hasenkamp, W., Ilkova, H., Patanè, G., Laybutt, R., Bonner-Weir, S., Weir, G.C., Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J. Biol. Chem. 274 (1999), 14112–14121.
18. Karwacz, K., Bricogne, C., MacDonald, D., Arce, F., Bennett, C.L., Collins, M., Escors, D., PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells. EMBO Mol. Med. 3 (2011), 581–592.
19. Keenan, H.A., Sun, J.K., Levine, J., Doria, A., Aiello, L.P., Eisenbarth, G., Bonner-Weir, S., King, G.L., Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 59 (2010), 2846–2853.
20. Krogvold, L., Skog, O., Sundström, G., Edwin, B., Buanes, T., Hanssen, K.F., Ludvigsson, J., Grabherr, M., Korsgren, O., Dahl-Jørgensen, K., Function of isolated pancreatic islets from patients at onset of type 1 diabetes: insulin secretion can be restored after some days in a nondiabetogenic environment in vitro: results from the DiViD study. Diabetes 64 (2015), 2506–2512.
21. Laybutt, D.R., Glandt, M., Xu, G., Ahn, Y.B., Trivedi, N., Bonner-Weir, S., Weir, G.C., Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes. J. Biol. Chem. 278 (2003), 2997–3005.
22. Lee, M., Choi, B., Kwon, H.J., Shim, J.A., Park, K.S., Lee, E.S., Sohn, S., The role of Qa-2, the functional homolog of HLA-G, in a Behcet's disease-like mouse model induced by the herpes virus simplex. J. Inflamm. (Lond.), 7, 2010, 31.
23. Li, B., Dewey, C.N., RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome. BMC Bioinformatics, 12, 2011, 323.
24. Liu, E.H., Digon, B.J. 3rd, Hirshberg, B., Chang, R., Wood, B.J., Neeman, Z., Kam, A., Wesley, R.A., Polly, S.M., Hofmann, R.M., et al. Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft. Diabetologia 52 (2009), 1369–1380.
25. Md Moin, A.S., Dhawan, S., Shieh, C., Butler, P.C., Cory, M., Butler, A.E., Increased hormone-negative endocrine cells in the pancreas in type 1 diabetes. J. Clin. Endocrinol. Metab. 101 (2016), 3487–3496.
26. Pearce, D.J., Taussig, D., Simpson, C., Allen, K., Rohatiner, A.Z., Lister, T.A., Bonnet, D., Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells 23 (2005), 752–760.
27. Riteau, B., Rouas-Freiss, N., Menier, C., Paul, P., Dausset, J., Carosella, E.D., HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J. Immunol. 166 (2001), 5018–5026.
28. Robinson, M.D., McCarthy, D.J., Smyth, G.K., edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26 (2010), 139–140.
29. Rouas-Freiss, N., Gonçalves, R.M., Menier, C., Dausset, J., Carosella, E.D., Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. USA 94 (1997), 11520–11525.
30. Rui, J., Deng, S., Lebastchi, J., Clark, P.L., Usmani-Brown, S., Herold, K.C., Methylation of insulin DNA in response to proinflammatory cytokines during the progression of autoimmune diabetes in NOD mice. Diabetologia 59 (2016), 1021–1029.
31. Sherry, N.A., Kushner, J.A., Glandt, M., Kitamura, T., Brillantes, A.M., Herold, K.C., Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes 55 (2006), 3238–3245.
32. Sreenan, S., Pick, A.J., Levisetti, M., Baldwin, A.C., Pugh, W., Polonsky, K.S., Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes 48 (1999), 989–996.
33. Steele, C., Hagopian, W.A., Gitelman, S., Masharani, U., Cavaghan, M., Rother, K.I., Donaldson, D., Harlan, D.M., Bluestone, J., Herold, K.C., Insulin secretion in type 1 diabetes. Diabetes 53 (2004), 426–433.
34. Talchai, C., Xuan, S., Lin, H.V., Sussel, L., Accili, D., Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell 150 (2012), 1223–1234.
35. Tersey, S.A., Nishiki, Y., Templin, A.T., Cabrera, S.M., Stull, N.D., Colvin, S.C., Evans-Molina, C., Rickus, J.L., Maier, B., Mirmira, R.G., Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes 61 (2012), 818–827.
36. Tsang, K.Y., Chan, D., Bateman, J.F., Cheah, K.S., In vivo cellular adaptation to ER stress: survival strategies with double-edged consequences. J. Cell Sci. 123 (2010), 2145–2154.
37. Tzima, E., Irani-Tehrani, M., Kiosses, W.B., Dejana, E., Schultz, D.A., Engelhardt, B., Cao, G., DeLisser, H., Schwartz, M.A., A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437 (2005), 426–431.
38. von Herrath, M., Sanda, S., Herold, K., Type 1 diabetes as a relapsing-remitting disease?. Nat. Rev. Immunol. 7 (2007), 988–994.
39. Wei, D., Loeken, M.R., Increased DNA methyltransferase 3b (Dnmt3b)-mediated CpG island methylation stimulated by oxidative stress inhibits expression of a gene required for neural tube and neural crest development in diabetic pregnancy. Diabetes 63 (2014), 3512–3522.